PharmaShots February Edition magazine explores the elements of dealmaking in the life sciences and healthcare sector. The magazine unfolds an engaging article followed by illustrative infographics and illuminating BioTrends. The magazine sheds light on key regulatory updates and also includes a few amazing facts on collaboration deals, and mergers & acquisitions. 

PharmaShots welcomed the year with sheer enthusiasm and zeal. Apart from the daily influx of news from the industry, PharmaShots was busy preparing the highlights of the year. Our most anticipated dealmaking reports featured Roche and Pfizer. Our quarterly digest featured the key highlights of Q4’23.  

Like every month our insights + section featured reposts on key biosimilar events, FDA approvals, and EMA approvals followed by Designation Report. The disease of the month report featured an illuminating article on Glioblastoma and for the Top Performing Drug, PharmaShots presented a comprehensive guide to Perjeta. In our Know Your Investor section, we provided a brief overview of RA Capital Management LLC. 

Our ThoughtSpot section featured an informative report on, Targeted Therapy in Oncology and two guest posts titled How Has Kratom Paved Its Way From Being A Dangerous Drug To A Mainstream Supplement? & Seven Traits of Nursing Leaders. 

Our most-read Top 20 report featured a condensed guide to Top 20 Biopharma M&A of 2023 by Total Deal Value.  Last Month we covered an exclusive interview with Noelle Bush, Director, of Marketing at Boehringer Ingelheim. 

Want to advertise in PharmaShots Magazine for FREE? Email us at connect@pharmashots.com